FarnooshFarrokhiMD

PubMed

• Technology and health inequities in diabetes care: How do we widen access to underserved populations and utilize technology to improve outcomes for all?
  Osagie Ebekozien, Kathryn Fantasia, Farnoosh Farrokhi, Ashutosh Sabharwal, David Kerr> ;Diabetes, Obesity & Metabolism. 2024 Mar 1
• 37 citations
  The impact of hyperglycemia and obesity on hospitalization costs and clinical outcome in general surgery patients.
  Lauren Buehler, Maya Fayfman, Anastasia-Stefania Alexopoulos, Liping Zhao, Farnoosh Farrokhi, Jeff Weaver, Dawn Smiley-Byrd, Francisco J. Pasquel, Priyathama Vellanki,...> ;Journal of Diabetes and Its Complications. 2015 Nov 1
• 6 citations
  COMPARISON OF BASAL INSULIN REGIMENS ON GLYCEMIC VARIABILITY IN NONCRITICALLY ILL PATIENTS WITH TYPE 2 DIABETES.
  J. Sonya Haw, Farnoosh Farrokhi, Dawn Smiley, Limin Peng, David Reyes, Christopher Newton, Francisco J. Pasquel, Priyathama Vellanki, Guillermo E. Umpierrez> ;Endocrine Practice. 2015 Aug 26
• 19 citations
  Randomized Controlled Trial of Insulin Supplementation for Correction of Bedtime Hyperglycemia in Hospitalized Patients With Type 2 Diabetes
  Priyathama Vellanki, Rachel Bean, Festus A. Oyedokun, Francisco J. Pasquel, Dawn Smiley, Farnoosh Farrokhi, Christopher Newton, Limin Peng, Guillermo E. Umpierrez> ;Diabetes Care. 2015 Apr 1
• 36 citations
  Glucose variability is an independent predictor of mortality in hospitalized patients treated with total parenteral nutrition.
  Farnoosh Farrokhi, Prakash Chandra, Dawn Smiley, Francisco J. Pasquel, Limin Peng, Christopher A. Newton, Guillermo E. Umpierrez> ;Endocrine Practice. 2014 Jan 1
• 109 citations
  Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes A pilot, randomized, controlled s...
  Guillermo E. Umpierrez, Roma Y. Gianchandani, Dawn Smiley, Sol Jacobs, David H. Wesorick, Christopher Newton, Farnoosh Farrokhi, Limin Peng, David Reyes, Sangeeta Lath...> ;Diabetes Care. 2013 Nov 1
• 55 citations
  Risk factors for inpatient hypoglycemia during subcutaneous insulin therapy in non-critically ill patients with type 2 diabetes.
  Farnoosh Farrokhi, Olena Klindukhova, Prakash Chandra, Limin Peng, Dawn Smiley, Christopher Newton, Francisco J. Pasquel, Maria Eugenia Fereira, Guillermo E. Umpierrez> ;Journal of Diabetes Science and Technology. 2012 Sep 1
• 75 citations
  Glycemic control in non-diabetic critically ill patients
  Farnoosh Farrokhi, Dawn Smiley, Guillermo E. Umpierrez> ;Best Practice & Research. Clinical Endocrinology & Metabolism. 2011 Oct 1
• 6 citations
  Etanercept-induced hypoglycemia and improved glycemic control in a patient with type 2 diabetes.
  Farnoosh Farrokhi, Harris C. Taylor, Nancy M McBride> ;Endocrine Practice. 2011 Mar 1
• 76 citations
  A new pH catheter for laryngopharyngeal reflux: Normal values.
  George Sun, Srikant Muddana, James C. Slaughter, Sean Casey, Eric M. Hill, Farnoosh Farrokhi, C. Gaelyn Garrett, Michael F. Vaezi> ;The Laryngoscope. 2009 Aug 1
• 57 citations
  Idiopathic (primary) achalasia
  Farnoosh Farrokhi, Michael F. Vaezi> ;Orphanet Journal of Rare Diseases. 2007 Sep 26
• 50 citations
  Extra-esophageal manifestations of gastroesophageal reflux.
  Farnoosh Farrokhi, Mf F. Vaezi> ;Oral Diseases. 2007 Jul 1
• 11 citations
  Laryngeal disorders in patients with gastroesophageal reflux disease.
  Farnoosh Farrokhi, Michael F. Vaezi> ;Minerva Gastroenterologica e Dietologica. 2007 Jun 1
• 27 citations
  Injection of botulinum toxin before pneumatic dilatation in achalasia treatment: a randomized-controlled trial.
  Javad Mikaeli, Faraz Bishehsari, Ghodratollah Montazeri, Mahboobeh Mahdavinia, Mohammad Yaghoobi, S Darvish-Moghadam, Farnoosh Farrokhi, Shahram Shirani, Arezoo Estakh...> ;Alimentary Pharmacology & Therapeutics. 2006 Sep 1
• 19 citations
  Gender effect on clinical features of achalasia: a prospective study
  Javad Mikaeli, Farnoosh Farrokhi, Faraz Bishehsari, Mahboobeh Mahdavinia, Reza Malekzadeh> ;BMC Gastroenterology. 2006 Apr 1
• A randomized prospective trial of oral versus intravenous ganciclovir for prophylaxis of cytomegalovirus infection and disease in high-risk kidney recipients.
  Nafar, M., Pezeshki, M. L., Farrokhi, F., Einollahi, B., Pour-Reza-Gholi, F., Firouzan, A., Farhangi, S.> ;Transplant Proc. 2005 Sep
• Living unrelated versus living related kidney transplantation: 20 years' experience with 2155 cases.
  Simforoosh, N., Basiri, A., Fattahi, M. R., Einollahi, B., Firouzan, A., Pour-Reza-Gholi, F., Nafar, M., Farrokhi, F.> ;Transplant Proc. 2006 Mar
• Pregnancy in kidney transplant recipients.
  Pour-Reza-Gholi, F., Nafar, M., Farrokhi, F., Entezari, A., Taha, N., Firouzan, A., Einollahi, B.> ;Transplant Proc. 2005 Sep
• Signs and symptoms of cytomegalovirus disease in kidney transplant recipients.
  Pour-Reza-Gholi, F., Labibi, A., Farrokhi, F., Nafar, M., Firouzan, A., Einollahi, B.> ;Transplant Proc. 2005 Sep
• Kidney retransplantation in comparison with first kidney transplantation.
  Pour-Reza-Gholi, F., Nafar, M., Saeedinia, A., Farrokhi, F., Firouzan, A., Simforoosh, N., Basiri, A., Einollahi, B.> ;Transplant Proc. 2005 Sep
• Potential risk factors for hypersensitization reflected by panel-reactive antibodies in dialysis patients.
  Pour-Reza-Gholi, F., Daneshvar, S., Nafar, M., Firouzan, A., Farrokhi, F., Einollahi, B.> ;Transplant Proc. 2005 Sep
• Join now to see all